Citigroup
CTSO icon

Citigroup’s Cytosorbents Corp CTSO Stock Holding History

Citigroup’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-420
Closed -$1K – 5901
2022
Q2 		$1K Sell
420
-1,064
-72% -$2.44K ﹤0.01% 5998
2022
Q1 		$5K Sell
1,484
-9,331
-86% -$33.4K ﹤0.01% 5802
2021
Q4 		$45K Buy
10,815
+5,870
+119% +$32.9K ﹤0.01% 5113
2021
Q3 		$40K Buy
4,945
+2,983
+152% +$24.2K ﹤0.01% 4860
2021
Q2 		$15K Sell
1,962
-757
-28% -$6.38K ﹤0.01% 5461
2021
Q1 		$24K Sell
2,719
-5,113
-65% -$48.7K ﹤0.01% 5130
2020
Q4 		$62K Buy
7,832
+5,859
+297% +$49K ﹤0.01% 5891
2020
Q3 		$16K Sell
1,973
-2,709
-58% -$24.4K ﹤0.01% 6323
2020
Q2 		$46K Sell
4,682
-4,137
-47% -$38K ﹤0.01% 6065
2020
Q1 		$68K Buy
8,819
+2,531
+40% +$12.8K ﹤0.01% 5680
2019
Q4 		$24K Buy
6,288
+2,166
+53% +$9.45K ﹤0.01% 6833
2019
Q3 		$21K Sell
4,122
-4,455
-52% -$25.9K ﹤0.01% 6703
2019
Q2 		$57K Buy
8,577
+531
+7% +$3.65K ﹤0.01% 6342
2019
Q1 		$61K Buy
8,046
+1,096
+16% +$8.54K ﹤0.01% 6170
2018
Q4 		$56K Sell
6,950
-1,223
-15% -$12.1K ﹤0.01% 6136
2018
Q3 		$105K Buy
8,173
+4,096
+100% +$51.4K ﹤0.01% 5849
2018
Q2 		$46K Buy
+4,077
New +$38.6K ﹤0.01% 6349
2016
Q2 		– Sell
-167
Closed -$1K – 7120
2016
Q1 		$1K Buy
+167
New +$725 ﹤0.01% 7282
2015
Q4 		– Sell
-406
Closed -$3K – 7599
2015
Q3 		$3K Sell
406
-381
-48% -$2.54K ﹤0.01% 6906
2015
Q2 		$5K Buy
+787
New +$5.35K ﹤0.01% 6736

Other funds holding CTSO

SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Citigroup's CTSO Position: Q3 2022 in Review

Citigroup sold out of Cytosorbents Corp (CTSO) in Q3 2022, closing a stake of 420 shares — an estimated $1K sold.

Citigroup first reported a position in CTSO in Q2 2015 and held it in 20 quarters. The position peaked at $105K in Q3 2018. 60 funds tracked by Wall St. Rank hold CTSO as of Q3 2022.

  • Citigroup reported no remaining Cytosorbents Corp position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 420 Cytosorbents Corp shares in Q3 2022, an estimated $1K.
  • Citigroup first reported a position in Cytosorbents Corp in Q2 2015 and held it in 20 quarters.
  • Citigroup's Cytosorbents Corp position peaked at $105K in Q3 2018.
  • 60 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.